BG105499A - Мембрана или матрица за контролирано проникване на лекарствено средство - Google Patents
Мембрана или матрица за контролирано проникване на лекарствено средство Download PDFInfo
- Publication number
- BG105499A BG105499A BG105499A BG10549901A BG105499A BG 105499 A BG105499 A BG 105499A BG 105499 A BG105499 A BG 105499A BG 10549901 A BG10549901 A BG 10549901A BG 105499 A BG105499 A BG 105499A
- Authority
- BG
- Bulgaria
- Prior art keywords
- siloxane
- elastomer
- polymer
- substituted
- groups
- Prior art date
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 29
- 229940079593 drug Drugs 0.000 title claims abstract description 25
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 239000011159 matrix material Substances 0.000 title abstract 2
- 229920001971 elastomer Polymers 0.000 claims abstract description 66
- 239000000806 elastomer Substances 0.000 claims abstract description 66
- -1 siloxane units Chemical group 0.000 claims abstract description 55
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims abstract description 44
- 238000000034 method Methods 0.000 claims abstract description 10
- 229920000642 polymer Polymers 0.000 claims description 55
- 230000035515 penetration Effects 0.000 claims description 23
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 21
- 239000000945 filler Substances 0.000 claims description 13
- 125000001424 substituent group Chemical group 0.000 claims description 9
- 125000000725 trifluoropropyl group Chemical group [H]C([H])(*)C([H])([H])C(F)(F)F 0.000 claims description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 abstract description 23
- 239000003054 catalyst Substances 0.000 abstract description 13
- 150000002978 peroxides Chemical class 0.000 abstract description 7
- 239000003431 cross linking reagent Substances 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 abstract 2
- 229910052710 silicon Inorganic materials 0.000 abstract 2
- 239000010703 silicon Substances 0.000 abstract 2
- 238000004132 cross linking Methods 0.000 description 15
- 125000001153 fluoro group Chemical group F* 0.000 description 9
- 239000000377 silicon dioxide Substances 0.000 description 9
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 8
- 238000006467 substitution reaction Methods 0.000 description 8
- 229920002554 vinyl polymer Polymers 0.000 description 8
- 125000004429 atom Chemical group 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 150000004678 hydrides Chemical class 0.000 description 6
- 238000003825 pressing Methods 0.000 description 6
- 229940088679 drug related substance Drugs 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 239000004971 Cross linker Substances 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical group OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 239000000599 controlled substance Substances 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- KAKZBPTYRLMSJV-UHFFFAOYSA-N vinyl-ethylene Natural products C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 3
- YSGQGNQWBLYHPE-CFUSNLFHSA-N (7r,8r,9s,10r,13s,14s,17s)-17-hydroxy-7,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound C1C[C@]2(C)[C@@H](O)CC[C@H]2[C@@H]2[C@H](C)CC3=CC(=O)CC[C@@H]3[C@H]21 YSGQGNQWBLYHPE-CFUSNLFHSA-N 0.000 description 2
- YSGQGNQWBLYHPE-UHFFFAOYSA-N 17-hydroxy-7,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound C1CC2(C)C(O)CCC2C2C(C)CC3=CC(=O)CCC3C21 YSGQGNQWBLYHPE-UHFFFAOYSA-N 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 229940030486 androgens Drugs 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000013065 commercial product Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000006459 hydrosilylation reaction Methods 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920000438 poly[methyl(3,3,3-trifluoropropyl)siloxane] polymer Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 description 1
- QYLFHLNFIHBCPR-UHFFFAOYSA-N 1-ethynylcyclohexan-1-ol Chemical compound C#CC1(O)CCCCC1 QYLFHLNFIHBCPR-UHFFFAOYSA-N 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 230000000708 anti-progestin effect Effects 0.000 description 1
- 239000003418 antiprogestin Substances 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000005331 crown glasses (windows) Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- CKFBRGLGTWAVLG-GOMYTPFNSA-N elcometrine Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC(=C)[C@](OC(=O)C)(C(C)=O)[C@@]1(C)CC2 CKFBRGLGTWAVLG-GOMYTPFNSA-N 0.000 description 1
- 229950007611 elcometrine Drugs 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- SIGSPDASOTUPFS-XUDSTZEESA-N gestodene Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](C=C4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 SIGSPDASOTUPFS-XUDSTZEESA-N 0.000 description 1
- 229960005352 gestodene Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960004400 levonorgestrel Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229940097156 peroxyl Drugs 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229940126703 systemic medication Drugs 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/009—Sachets, pouches characterised by the material or function of the envelope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/2036—Silicones; Polysiloxanes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Silicon Polymers (AREA)
- Materials For Medical Uses (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/190,608 US6056976A (en) | 1998-11-12 | 1998-11-12 | Elastomer, its preparation and use |
| PCT/FI1999/000888 WO2000029464A1 (en) | 1998-11-12 | 1999-10-26 | Novel membrane or matrix for controlling drug permeation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG105499A true BG105499A (bg) | 2001-12-29 |
Family
ID=22702039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG105499A BG105499A (bg) | 1998-11-12 | 2001-05-11 | Мембрана или матрица за контролирано проникване на лекарствено средство |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6056976A (xx) |
| EP (1) | EP1151030A1 (xx) |
| JP (1) | JP2002530447A (xx) |
| KR (1) | KR20010075701A (xx) |
| CN (1) | CN1127535C (xx) |
| AR (1) | AR025815A1 (xx) |
| AU (1) | AU756089B2 (xx) |
| BG (1) | BG105499A (xx) |
| BR (1) | BR9915325A (xx) |
| CA (1) | CA2351091A1 (xx) |
| CZ (1) | CZ291399B6 (xx) |
| DE (1) | DE1151030T1 (xx) |
| EE (1) | EE05528B1 (xx) |
| HK (1) | HK1041895B (xx) |
| HU (1) | HUP0104380A3 (xx) |
| ID (1) | ID29223A (xx) |
| IL (2) | IL142525A0 (xx) |
| NO (1) | NO20012045L (xx) |
| NZ (1) | NZ511215A (xx) |
| PE (1) | PE20001019A1 (xx) |
| PL (1) | PL348115A1 (xx) |
| RU (1) | RU2231531C2 (xx) |
| SK (1) | SK5142001A3 (xx) |
| WO (1) | WO2000029464A1 (xx) |
| ZA (1) | ZA200103297B (xx) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6214926B1 (en) * | 1999-04-01 | 2001-04-10 | Rhodia Inc. | Silicone membranes formed without the use of 1-1-1 trichloroethane |
| US6436428B1 (en) * | 2000-03-21 | 2002-08-20 | Enhance Pharmaceuticals, Inc. | Device and method for treating urinary incontinence in females |
| US6299894B1 (en) | 2000-05-10 | 2001-10-09 | Leiras Oy | Drug delivery device, especially for the delivery of gestodene |
| WO2001085132A1 (en) * | 2000-05-10 | 2001-11-15 | Leiras Oy | Drug delivery device, especially for the delivery of levonorgestrel |
| US6550480B2 (en) * | 2001-01-31 | 2003-04-22 | Numed/Tech Llc | Lumen occluders made from thermodynamic materials |
| EP1438942A1 (en) * | 2003-01-17 | 2004-07-21 | Schering Oy | An otorhinological drug delivery device |
| US20050038188A1 (en) * | 2003-08-14 | 2005-02-17 | Dongchan Ahn | Silicones having improved chemical resistance and curable silicone compositions having improved migration resistance |
| US20050038183A1 (en) * | 2003-08-14 | 2005-02-17 | Dongchan Ahn | Silicones having improved surface properties and curable silicone compositions for preparing the silicones |
| US7045586B2 (en) * | 2003-08-14 | 2006-05-16 | Dow Corning Corporation | Adhesives having improved chemical resistance and curable silicone compositions for preparing the adhesives |
| US7862552B2 (en) * | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
| US20090168013A1 (en) * | 2007-12-27 | 2009-07-02 | Kunzler Jay F | Trimethylsilyl-Capped Polysiloxane Macromonomers Containing Polar Fluorinated Side-Chains |
| ES2648640T3 (es) | 2008-02-04 | 2018-01-04 | Ferring B.V. | Anillos intravaginales monolíticos que comprenden progesterona y métodos de fabricación y usos de los mismos |
| EP2140860A1 (en) | 2008-07-03 | 2010-01-06 | Bayer Schering Pharma Oy | An improved method of contraception |
| FI20080524A0 (fi) | 2008-09-17 | 2008-09-17 | Bayer Schering Pharma Oy | Insertteri |
| FI20080523A0 (fi) | 2008-09-17 | 2008-09-17 | Bayer Schering Pharma Oy | Insertteri |
| US11992431B2 (en) | 2008-09-17 | 2024-05-28 | Bayer Oy | Inserter |
| PT2349143E (pt) | 2008-09-17 | 2013-07-08 | Bayer Oy | Um dispositivo de inserção |
| RU2411077C1 (ru) * | 2009-06-09 | 2011-02-10 | Государственное образовательное учреждение высшего профессионального образования "Тверской государственный технический университет" | Способ получения оболочек на основе хитозана и солей альгиновой кислоты для микрокапсул, содержащих фосфолипидные мицеллы |
| FI122579B (fi) | 2010-10-29 | 2012-03-30 | Bayer Oy | Insertteri |
| US10028858B2 (en) | 2011-07-11 | 2018-07-24 | Medicines360 | Intrauterine systems, IUD insertion devices, and related methods and kits therefor |
| BR112014026086A2 (pt) | 2012-04-23 | 2017-07-18 | Bayer Pharma AG | aplicação de 18-metil-15beta,16beta-metilen-19-nor-20-spirox-4-en-3-onas na terapia da menorragia, bem como sistemas intrauterinos contendo 18-metil-15beta,16beta-metilen-19-nor-20-spirox-4-en-3-onas para a terapia de distúrbios de sangramento uterino |
| TW201350122A (zh) | 2012-04-23 | 2013-12-16 | Bayer Pharma AG | １８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內用途，包含１８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內系統，及其於避孕及婦科治療之用途 |
| USD718435S1 (en) | 2012-05-30 | 2014-11-25 | Medicines360 | Intrauterine insertion device |
| WO2015055635A1 (en) * | 2013-10-18 | 2015-04-23 | Bayer Oy | Intrauterine delivery system |
| KR102431597B1 (ko) * | 2014-12-31 | 2022-08-11 | 엘지디스플레이 주식회사 | 전기활성 필름을 포함하는 접촉 감응 소자, 이를 포함하는 표시 장치 및 전기활성 필름의 제조 방법 |
| EP3040388B1 (en) | 2014-12-31 | 2017-08-23 | LG Display Co., Ltd. | Touch sensitive device comprising electroactive film, display device comprising the same, and method of manufacturing the electroactive film |
| US11096888B2 (en) | 2015-05-13 | 2021-08-24 | Bayer Oy | Long acting drug delivery device and its use in contraception |
| WO2018202574A1 (en) | 2017-05-04 | 2018-11-08 | Bayer Oy | Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception |
| WO2019119059A1 (en) | 2017-12-22 | 2019-06-27 | Alyra Biotech Pty Ltd | Treatment of pain and/or pain related symptoms associated with dysmenorrhea |
| US11571328B2 (en) | 2018-04-09 | 2023-02-07 | Medicines360 | IUD insertion devices |
| US20200261258A1 (en) | 2019-02-19 | 2020-08-20 | Medicines360 | Devices, systems, methods and kits for insertion and removal of iuds |
| EP3976013A4 (en) | 2019-05-31 | 2023-05-31 | Alyra Biotech Pty Ltd | METHODS, COMPOSITIONS AND DEVICES FOR THE TREATMENT OF NEUROINFLAMMATORY CONDITIONS |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3050492A (en) * | 1962-08-21 | Degrees of twist at indicated centigrade temperature | ||
| US3179619A (en) * | 1965-04-20 | Xow swell, high temperature organosi- loxane rubbeks containing silicon- bonded fluokjnated aliphatic radicals | ||
| US3279996A (en) * | 1962-08-28 | 1966-10-18 | Jr David M Long | Polysiloxane carrier for controlled release of drugs and other agents |
| US3854480A (en) * | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US3661833A (en) * | 1970-07-09 | 1972-05-09 | Dow Corning | Fast curing organosiloxane resins |
| US3974120A (en) * | 1975-05-05 | 1976-08-10 | General Electric Company | Fluorosilicone copolymers and process for the preparation thereof |
| CH657779A5 (de) * | 1982-10-05 | 1986-09-30 | Sandoz Ag | Galenische zusammensetzungen enthaltend calcitonin. |
| US4525528A (en) * | 1983-10-11 | 1985-06-25 | General Electric Company | Peroxide-curable fluorosilicone copolymer compositions |
| NZ217844A (en) * | 1985-10-11 | 1989-10-27 | Sumitomo Pharma | A sustained release pharmaceutical composition containing silicone elastomer and an albumin |
| US5310572A (en) * | 1987-02-03 | 1994-05-10 | Dow Corning Corporation | Process for forming a coated active agent-containing article |
| GB8704755D0 (en) * | 1987-02-28 | 1987-04-01 | Dow Corning Ltd | Pharmaceutical delivery device |
| IL91398A (en) * | 1988-08-30 | 1994-05-30 | Pfizer | Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane |
| FR2643572A1 (fr) * | 1988-12-22 | 1990-08-31 | Rhone Poulenc Chimie | Procede d'encapsulation de particules par pelliculage au moyen d'un copolymere silicone thermoplastique |
| SE9202250D0 (sv) * | 1992-07-29 | 1992-07-29 | Gacell Lab Ab | Controlled release morphine preparation |
| JPH07216233A (ja) * | 1992-09-21 | 1995-08-15 | Toray Dow Corning Silicone Co Ltd | フルオロシリコーンゴム組成物 |
| US5492993A (en) * | 1994-02-03 | 1996-02-20 | Dow Corning Corporation | Strain-crystallizing poly(methyl(3,3,3-trifluoropropyl)-siloxane) elastomers and methods for making |
| EP0688564B1 (en) * | 1994-06-20 | 1999-08-04 | Dow Corning Corporation | Method of controlling release of an active substance or drug from a silicone rubber matrix |
| US5597384A (en) * | 1994-09-13 | 1997-01-28 | Zimmer, Inc. | Color coding for implant selection |
-
1998
- 1998-11-12 US US09/190,608 patent/US6056976A/en not_active Expired - Lifetime
-
1999
- 1999-10-26 KR KR1020017006011A patent/KR20010075701A/ko not_active Ceased
- 1999-10-26 CN CN99813193A patent/CN1127535C/zh not_active Expired - Fee Related
- 1999-10-26 CA CA002351091A patent/CA2351091A1/en not_active Abandoned
- 1999-10-26 SK SK514-2001A patent/SK5142001A3/sk unknown
- 1999-10-26 BR BR9915325-4A patent/BR9915325A/pt not_active IP Right Cessation
- 1999-10-26 JP JP2000582447A patent/JP2002530447A/ja active Pending
- 1999-10-26 NZ NZ511215A patent/NZ511215A/en not_active IP Right Cessation
- 1999-10-26 HK HK02103478.3A patent/HK1041895B/zh not_active IP Right Cessation
- 1999-10-26 CZ CZ20011570A patent/CZ291399B6/cs not_active IP Right Cessation
- 1999-10-26 IL IL14252599A patent/IL142525A0/xx active IP Right Grant
- 1999-10-26 RU RU2001116121/04A patent/RU2231531C2/ru not_active IP Right Cessation
- 1999-10-26 PL PL99348115A patent/PL348115A1/xx not_active Application Discontinuation
- 1999-10-26 HU HU0104380A patent/HUP0104380A3/hu unknown
- 1999-10-26 AU AU10489/00A patent/AU756089B2/en not_active Ceased
- 1999-10-26 ID IDW00200101066A patent/ID29223A/id unknown
- 1999-10-26 EP EP99954021A patent/EP1151030A1/en not_active Withdrawn
- 1999-10-26 WO PCT/FI1999/000888 patent/WO2000029464A1/en not_active Ceased
- 1999-10-26 EE EEP200100257A patent/EE05528B1/xx not_active IP Right Cessation
- 1999-10-26 DE DE1151030T patent/DE1151030T1/de active Pending
- 1999-11-05 PE PE1999001124A patent/PE20001019A1/es not_active Application Discontinuation
- 1999-11-11 AR ARP990105742A patent/AR025815A1/es not_active Application Discontinuation
-
2001
- 2001-04-10 IL IL142525A patent/IL142525A/en not_active IP Right Cessation
- 2001-04-23 ZA ZA200103297A patent/ZA200103297B/xx unknown
- 2001-04-26 NO NO20012045A patent/NO20012045L/no unknown
- 2001-05-11 BG BG105499A patent/BG105499A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20012045L (no) | 2001-06-28 |
| US6056976A (en) | 2000-05-02 |
| ID29223A (id) | 2001-08-16 |
| EE05528B1 (et) | 2012-04-16 |
| NZ511215A (en) | 2002-04-26 |
| PE20001019A1 (es) | 2000-10-12 |
| HUP0104380A2 (hu) | 2002-03-28 |
| EE200100257A (et) | 2002-12-16 |
| IL142525A0 (en) | 2002-03-10 |
| BR9915325A (pt) | 2001-10-09 |
| CN1127535C (zh) | 2003-11-12 |
| CA2351091A1 (en) | 2000-05-25 |
| AR025815A1 (es) | 2002-12-18 |
| AU1048900A (en) | 2000-06-05 |
| CZ291399B6 (cs) | 2003-02-12 |
| PL348115A1 (en) | 2002-05-06 |
| EP1151030A1 (en) | 2001-11-07 |
| HK1041895B (zh) | 2004-07-23 |
| RU2231531C2 (ru) | 2004-06-27 |
| HUP0104380A3 (en) | 2003-04-28 |
| DE1151030T1 (de) | 2002-04-04 |
| SK5142001A3 (en) | 2001-11-06 |
| CN1326478A (zh) | 2001-12-12 |
| JP2002530447A (ja) | 2002-09-17 |
| WO2000029464A1 (en) | 2000-05-25 |
| NO20012045D0 (no) | 2001-04-26 |
| ZA200103297B (en) | 2001-10-25 |
| AU756089B2 (en) | 2003-01-02 |
| CZ20011570A3 (cs) | 2001-09-12 |
| KR20010075701A (ko) | 2001-08-09 |
| HK1041895A1 (en) | 2002-07-26 |
| IL142525A (en) | 2006-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG105499A (bg) | Мембрана или матрица за контролирано проникване на лекарствено средство | |
| KR100850548B1 (ko) | 항프로게스테론 특성을 가지는 약물의 전달 장치 | |
| EP1128811B1 (en) | Drug delivery device, especially for the delivery of progestins and estrogens | |
| EP1124902B1 (en) | A membrane or matrix for controlling the permeation rate of drugs | |
| EP1128810B1 (en) | Drug delivery device, especially for the delivery of androgens |